Aldo T. Iacono, M.D.

Associate Professor of Medicine
Medical Director, Lung Transplant Program

Department: Division
Lung Transplantation
Medicine: Pulmonary and Critical Care Medicine

Special Interests: Aerosolized cyclosporine as anti-rejection medication; preventing complications of lung transplantation

Medical Degree: University of Bologna (Italy)

Residency: SUNY Downstate, Brooklyn Hospital

Fellowship: SUNY Stony Brook, Pulmonary & Critical Care Medicine

Certification: Internal Medicine; Pulmonary Diseases; Critical Care Medicine

Biography:Dr. Iacono recently joined the University of Maryland faculty from University of Pittsburgh School of Medicine where he served as Medical Director of Lung Transplantation. Dr. Iacono has established a national reputation as an outstanding transplant pulmonologist and a translational investigator focusing on novel anti-rejection therapy. He has been a leader in developing aerosolized anti-rejection therapy to reduce the incidence of chronic lung transplant rejection and minimize systemic side effects of anti-rejection medications. Current Research Interests: * Complications of lung transplantation * Markers of lung transplant rejection * Novel anti-rejection therapies * Aerosolized anti-rejection therapy for lung transplant patients Current Research Funding: * NIH R01 HL59490, ?Aerosol Cyclosporine as Prevention of Allograft Rejection? (PI: Iacono) Years: 1997-2001. Direct cost: 1,706,795, Total Budget: 2,376,085 * Chiron, ?Commercialization of Aerosol Cyclosporine? (PI: Iacono); Years: 2004-present. Total Budget: $110,000

Ask Dr. Iacono your lung transplant questions.

Contact Information:
1-800-373-4111 (physicians only)
1-800-492-5538 (patients and general information)
1-410-328-8919 (news media only)